While international charitable organizations and foreign aid have provided some temporary relief through donations of medicine and supplies, experts agree that short-term charity cannot replace a functioning national pharmaceutical supply chain.
As the World Bank has highlighted, maintaining upper-middle status requires not just recovery momentum but deep structural reforms to drive sustainable, inclusive growth.